Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Wenyu Wu
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Huashan Hospital
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Huashan Hospital
ORCID:
0000-0002-7540-4953
Observed ORCID:
0000-0002-7540-4953
OpenAlex ID:
A5146599889
Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
2026
·
Maryanne Senna
, Jennifer Soung
, et al.
·
American Journal of Clinical Dermatology
·
8
PDF
Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia‐Pacific Modified Delphi Expert Panel Recommendations
2026
·
Rodney Sinclair
, Chao‐Chun Yang
, et al.
·
International Journal of Dermatology
·
3
PDF
Expert consensus on systemic treatment activation and grading evaluation for alopecia areata
2025
·
Cheng Zhou
, Xufeng Du
, et al.
·
Chinese Medical Journal
·
2
Rutin Stabilises β‐Catenin Through GSK3β Inhibition to Promote Hair Follicle Regeneration
2026
·
Yanyan Zhang
, Yuanjie Zhu
, et al.
·
Cell Proliferation
·
1
Stapokibart as Add-on Therapy for Alopecia Areata with Elevated IgE and Relapse During Upadacitinib Treatment
2026
·
Qin Wang
, Ke Tao
, et al.
·
JAAD International
Hair transplantation for secondary cicatricial alopecia: A Chinese expert consensus
2026
·
Yingjie Zhao
, Jiaxian Zhang
, et al.
·
Journal of the European Academy of Dermatology and Venereology
Correction to: Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
2026
·
Maryanne Senna
, Jennifer Soung
, et al.
·
American Journal of Clinical Dermatology
PDF
Clinical Characteristics, Treatment Patterns, and Outcomes of Chinese Patients With Alopecia Areata: A Retrospective Observational Study
2026
·
Youyu Sheng
, Zhibing Qiu
, et al.
·
Journal of Cosmetic Dermatology
Short-term omalizumab as a potential rescue therapy for alopecia areata flares during Janus kinase inhibitor maintenance
2026
·
Qin Wang
, Ke Cheng
, et al.
·
JAAD International
PDF
Pediatric Clinical Trial Program in Progress: A Phase 3 Study and Long-term Extension Study to Evaluate the Efficacy and Safety of Ritlecitinib in Children 6 to <12 years of Age With Severe Alopecia Areata
2026
·
Bianca Piraccini
, Jennifer Soung
, et al.
·
SKIN The Journal of Cutaneous Medicine
PDF
Show more works
View as search
Works count:
10
Citation count:
14
H-index:
2
I10-index:
Year
Topic
Type